Glanzmann Thrombasthenia: Clinical Trials

3 trials for Glanzmann Thrombasthenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Terminated 1
Phase 22Active not recruiting 1, Terminated 1

Follow Glanzmann Thrombasthenia: new trials by email Literature Review of Glanzmann Thrombasthenia trials Research Report on Glanzmann Thrombasthenia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
HMB-001 - Glanzmann Thrombasthenia
Phase 1 / Phase 2Active not recruitingHemab ApS572022-12-132026-09-25
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
Coagulation Factor VIIa variant - Factor VII Deficiency, Glanzmann Thrombasthenia
Phase 1 / Phase 2TerminatedCatalyst Biosciences192021-05-172021-12-21
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Abatacept - Hurler Syndrome, Fanconi Anemia
Phase 1CompletedEmory University102014-01-012019-12-26

Narrower conditions

Thrombasthenia (3)  ·  Anemia, Aplastic (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Anemia, Sickle Cell (1)  ·  Chediak-Higashi Syndrome (1)  ·  Dyskeratosis Congenita (1)  ·  Factor VII Deficiency (1)  ·  Fanconi Anemia (1)  ·  Granulomatous Disease, Chronic (1)  ·  Leukocyte adhesion deficiency type 1 (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)  ·  Mucopolysaccharidosis I (1)  ·  Neutropenia, Severe Congenital, Autosomal Recessive 3 (1)  ·  Shwachman-Diamond Syndrome (1)  ·  Wiskott-Aldrich Syndrome (1)

Broader conditions

Blood Coagulation Disorders (3)  ·  Blood Coagulation Disorders, Inherited (3)  ·  Blood Platelet Disorders (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Albinism (1)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Anemia, Hypoplastic, Congenital (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Failure Disorders (1)

Interventions

Abatacept (1)

Sponsors

Catalyst Biosciences (1)  ·  Emory University (1)  ·  Hemab ApS (1)

Countries

United States (3)  ·  Italy (2)  ·  Belgium (1)  ·  France (1)  ·  India (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

John T Horan, MD (1)